Algal extract for use in the treatment or prevention of post-traumatic immunosuppression
Disclosed is an extract of algae of the order Ulvales, including sulfated and non-sulfated polyanionic polysaccharides, the molecular weight of which is less than or equal to 50 kDa, for use in the prevention and/or treatment of complications caused by post-traumatic immunosuppression.
1. A method for the prevention and/or treatment of a complication induced by post-traumatic immunosuppression in a subject in need thereof, said method comprising the administration to said subject of an effective amount of an algal extract of the order Ulvales comprising sulfated and non-sulfated polyanionic polysaccharides the molecular weight of which is less than or equal to 50 kDa, wherein the algal extract has no direct antibacterial effect and no direct effect on Staphylococcus aureus.
2. The method according to claim 1 , for treatment of a septic complication associated with post-traumatic immunosuppression.
3. The method according to claim 2 , wherein the said septic complication is a nosocomial infection.
4. The method according to claim 1 , wherein the said post-traumatic immunosuppression occurs as a consequence of one or more severe traumas.
5. The method according to claim 1 , wherein the said algal extract is an extract of green algae of the type Ulva.
6. The method according to claim 1 , wherein the said sulfated and non-sulfated polyanionic polysaccharides the molecular weight of which is less than or equal to 50 kDa, have a molecular weight that is less than 15 kDa.
7. The method according to claim 6 , wherein the algal extract does not comprise sulfated or non-sulfated polyanionic polysaccharides having a molecular weight that is greater than 15 kDa.
8. The method according to claim 1 , wherein the algal extract comprises:
mannose; and/or
arabinose; and/or
galactose; and/or
glucose; and/or
rhamnose; and/or
xylose; and/or
glucuronic acid.
9. The method according to claim 1 , wherein the algal extract comprises:
from 10 to 50% carbon;
from 1 to 10% hydrogen;
from 1 to 5% nitrogen;
from 20 to 50% oxygen; and
from 1 to 15% sulfur;
as a percentage by mass of the total dry matter (dry weight) of the algal extract.
10. The method according to claim 1 , wherein the algal extract is obtained by a method of preparation in which:
a) the algae are washed and desanded;
b) the said algae are ground;
c) the solid phase of the ground material is separated from its liquid phase;
d) the said liquid phase is clarified;
e) the juice obtained in step d) is ultra filtered through a membrane having pore size of 50 kDa or less; and
f) the filtration juice obtained in step e) is concentrated and then dried.
11. The method of claim 3 , wherein the nosocomial infection is selected from the group consisting of: pneumopathies, urinary tract infections, infections of central venous catheters, and bacterial cerebromeningeal infections.
12. The method of claim 4 , wherein the severe traumas is a severe cranial trauma.
13. The method of claim 1 , wherein said sulfated and non-sulfated polyanionic polysaccharides the molecular weight of which is less than or equal to 50 kDa, have a molecular weight that is less than 15 kDa, and greater than 500 Da.
14. The method according to claim 2 , wherein the said post-traumatic immunosuppression occurs as a consequence of one or more severe traumas.
15. The method according to claim 3 , wherein the said post-traumatic immunosuppression occurs as a consequence of one or more severe traumas.
16. The method according to claim 2 , wherein the said algal extract is an extract of green algae of the type Ulva.
17. The method according to claim 3 , wherein the said algal extract is an extract of green algae of the type Ulva.
18. The method according to claim 4 , wherein the said algal extract is an extract of green algae of the type Ulva.
19. The method according to claim 2 , wherein the said sulfated and non-sulfated polyanionic polysaccharides the molecular weight of which is less than or equal to 50 kDa, have a molecular weight that is less than 15 kDa.
20. The method according to claim 3 , wherein the said sulfated and non-sulfated polyanionic polysaccharides the molecular weight of which is less than or equal to 50 kDa, have a molecular weight that is less than 15 kDa.